Healthcare And PPE Market Potential Will Support Greater Share Price Upside

Narrative Update on Ansell Analysts have slightly reduced their fair value price target for Ansell from $36.77 to $36.41. They cite that despite unchanged forecasts and ongoing concerns over tariffs, the stock continues to appear undervalued based on current market conditions.

Analysts have raised their fair value estimate for Ansell from A$35.15 to A$36.77. They cited that the shares appear undervalued relative to forecast risks and the current discount in the stock price.

Ansell’s fair value has been revised down as the consensus Analyst Price Target fell from A$36.15 to A$35.15, primarily reflecting a sharp increase in the company’s Future P/E ratio despite a stable discount rate. What's in the News Ansell's Board authorized a share buyback plan.

Ansell’s consensus price target has increased slightly, primarily reflecting a higher future P/E despite a notable downgrade in revenue growth forecasts, resulting in a new fair value of A$36.21. What's in the News Board authorized a buyback plan.